Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

Bone Marrow Transplantation

Volumn 29, Issue 1, 2002, Pages 15-19

  Grow, W B ^a   Moreb, J S ^a   Roque, D ^a   Manion, K ^a   Leather, H ^a   Reddy, V ^a   Khan, S A ^a   Finiewicz, K J ^a   Nguyen, H ^a   Clancy, C J ^a   Mehta, P S ^a   Wingard, J R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aspergillosis; Bone marrow transplant; Corticosteroids; Fungal infections

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CORTICOSTEROID; CYCLOSPORIN A; FLUCONAZOLE; ITRACONAZOLE; METHOTREXATE; TACROLIMUS; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG FORMULATION; DRUG USE; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; RECIPIENT; REINFECTION; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL TIME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLORIDA; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSION; INFANT; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 85047699670     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703332     Document Type: Article

References (15)

1. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
2. Invasive aspergillosis developing during empirical antifungal therapy
3. Fungal infections in bone marrow transplant patients
4. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
5. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
6. Aspergillus infections in bone marrow transplant recipients
7. Variables predicting deep fungal infections in bone marrow transplant recipients
8. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis
9. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients
10. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: A 13 years' experience
11. Impact of air filtration on nosocomial aspergillus infections: Unique risk of bone marrow transplant recipients
12. Consensus conference on acute GVHD grading
13. Pharmacologic and biologic agents
14. An EORTC International Multicenter Randomized Trial (EORTC Number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
15. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients